National Bank of Canada
XENE icon

National Bank of Canada’s Xenon Pharmaceuticals XENE Stock Holding History

National Bank of Canada’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7K Buy
235
+45
+24% +$2.07K ﹤0.01% 2260
2025
Q4 		$8.52K Sell
190
-10
-5% -$420 ﹤0.01% 2347
2025
Q3 		$8.03K Sell
200
-35
-15% -$1.23K ﹤0.01% 2368
2025
Q2 		$7.35K Hold
235
– – ﹤0.01% 2413
2025
Q1 		$7.88K Hold
235
– – ﹤0.01% 2296
2024
Q4 		$9.21K Hold
235
– – ﹤0.01% 2347
2024
Q3 		$9.25K Hold
235
– – ﹤0.01% 2098
2024
Q2 		$8.83K Buy
+235
New +$9.39K ﹤0.01% 2150

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

National Bank of Canada's XENE Position: Q1 2026 in Review

National Bank of Canada increased its Xenon Pharmaceuticals (XENE) stake by 24% in Q1 2026, buying an estimated $2.07K and bringing the position to 235 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2260.

National Bank of Canada first reported a position in XENE in Q2 2024 and has held it in 8 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • National Bank of Canada held 235 shares of Xenon Pharmaceuticals worth $13.7K as of Q1 2026.
  • National Bank of Canada bought 45 Xenon Pharmaceuticals shares in Q1 2026, an estimated $2.07K.
  • Xenon Pharmaceuticals made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2260 holding.
  • National Bank of Canada first reported a position in Xenon Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.